Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Yves Dauvilliers(Inserm), Christian von Hehn(Biogen (United States)), Elizabeth Hanson(Linnaeus University), Thomas E. Scammell(Beth Israel Deaconess Medical Center), Philipp von Rosenstiel(Biogen (United States)), Harisha Kadali(Inserm), Yeting Du(Inserm), Seetha Meyer(Inserm), Rafael del Río Villegas(Universidad San Pablo CEU), Raquel Rogers(Inserm), Yuichi Inoue(Japan Research Institute), Giuseppe Plazzi(Istituto delle Scienze Neurologiche di Bologna), Jingtao Wu(Inserm), Naga Venkatesha Murthy(Inserm), Emmanuel Mignot(Palo Alto University), Zoltán Szakács(Buda Health Center), Sarah Sheikh(Biogen (United States)), Todd J. Swick(Takeda (United States)), Heidi Zeitz(Inserm), Elena Koundourakis(Inserm)
Cited by 93
Related Papers
Narcolepsy in orexin Knockout Mice
|Cell|1999|3.1k
Hypothalamic regulation of sleep and circadian rhythms
|Nature|2005|2.8k
The sleep switch: hypothalamic control of sleep and wakefulness
|Trends in Neurosciences|2001|1.6k
Sleep State Switching
|Neuron|2010|1.4k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k